The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID)
Open accessAbstract
SIgAD, using 0.05 g/l of serum IgA as the upper limit for diagnosis in adults and a concomitant lack of secretory IgA, is the most common form of primary immunodeficiency (PID) in the western world and affects approximately 1/600 individuals [1]. However, there is a marked variability in the prevalence in different ethnic groups [2], with a lower frequency in Japanese (1/18 000) and Chinese (1/4000), suggesting a genetic basis for the disorder. The term ‘selective IgAD’ should be reserved for those individuals who do not have identifiable disorders which are known to be associated with low IgA levels (see below). However, in many cases a simultaneous change in the IgG subclass pattern is seen with a lack of specific anti-polysaccharide antibodies of the IgG2 subclass [3] or a total lack of serum IgG2 [4], IgG4 and IgE [5], reflecting a relative or absolute block in switching to genes downstream of the G1. CVID affects about 1/25 000 Caucasians, the patients having a marked reduction in serum levels of both IgG (usually < 3 g/l) and IgA (< 0.05 g/l); IgM is also reduced in about half the patients (< 0.3 g/l) [1]. Symptoms of recurring infection can start at any time of life, but there are peaks of onset during 1–5 and 16–20 years of age [6], with equal distribution between the sexes. The condition is clinically more complex than X-linked agammaglobulinaemia (XLA), with patients being prone to chronic inflammatory and autoimmune complications [6, 7]. Familial inheritance of either SIgAD or CVID occurs in about 20% of cases (Fig. 1). A different population prevalence in various ethnic groups, strong familial clustering of the disorder, a predominant inheritance pattern in multiple-case families compatible with autosomal dominant transmission, and a high relative risk for siblings suggest the involvement of thus far unidentified genetic factors in the pathogenesis of IgAD/CVID [8, 9]. In multiple-case families with a dominant transmission of CVID/IgAD, CVID was usually present in the parents accompanied by IgAD in descendants [9]. This is consistent with the hypothesis that CVID may develop later in life as a more severe manifestation of a common, complex genetic defect, most likely involving immunoglobulin class switching. This is supported by a description of a gradual decline of IgG levels that progressed at similar ages in affected siblings [10]. Furthermore, CVID may develop from IgAD [11–13] and occasionally vice versa [14]. In both diseases anti-IgA antibodies have been detected. Since the disease phenotype is persistent and the phenocopy rate is low, chromosome susceptibility loci underlying this complex trait should be detectable by genetic linkage analysis. The recurrence risk of IgAD was found to depend on the gender of parents transmitting the defect: affected mothers are more likely to pass the defect on to their offspring than affected fathers. This was accompanied by a preferential transmission of associated alleles in the MHC, suggesting a role for this region in the parent-of-origin penetrance differences [9]. The role of the MHC is further supported by a higher prevalence of anti-IgA antibodies among females transmitting the disease to their offspring than in female non-transmitters. Fig. 1. Three pedigrees are shown demonstrating the inheritance patterns for IgAD and CVID. Note that in some families there are relatives with minor IgG abnormalities. Our recent study involving a large number of multiple-case families supported the presence of a predisposing locus in the class II or class III region [ 9]. A significant increase in sharing of MHC alleles in affected members of our family dataset was consistent with previous allelic associations observed in case control studies, which appear to be much stronger for IgAD than CVID. It is possible that the gene(s) involved predispose to the production of IgA antibodies. A number of abnormalities in the cytokine network have been observed in SIgAD and CVID; however, attempts to find a defect in candidate cytokine genes have so far failed, including the available coding region of the cytokine genes in the MHC, such as lymphotoxin α and β (Vorechovsky et al., unpublished). Using the same family material, we were unable to confirm a susceptibility locus on chromosome 18, despite a number of anecdotal reports of patients with gross defects in the 18p region and SIgAD [ 15]. The finding of immunoglobulin deficiency in only one of two monozygotic twins suggests an environmental, possibly infectious agent as a triggering factor, but longer follow up of these twins is needed [16]. In SIgAD the defect is manifested at the stem cell level, since a bone marrow transplant from an IgA-deficient donor transfers the defect to the recipient [ 17], whereas bone marrow from a normal individual transplanted into an SIgAD patient will correct the defect [18]. The genes for α1 and α2 can readily be demonstrated in the genome of IgAD patients [19] and these ‘silent’ genes
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Common Variable Immunodeficiency: Clinical and Immunological Features of 248 Patients
Cunningham-Rundles, C., & Bodian, C. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4725 · Cited by 1,516
Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B
Wahl, C., Liptay, S., Adler, G., & Schmid, R. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci992 · Cited by 742
Koni, P. A., Sacca, R., Lawton, P., Browning, J. L., Ruddle, N. H., & Flavell, R. A. (1997) · Immunity · doi:10.1016/s1074-7613(00)80292-7 · Cited by 589
Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications
Hermaszewski, R. A., & WEBSTER, A. D. B. (1993) · QJM · doi:10.1093/oxfordjournals.qjmed.a068735 · Cited by 567
Banks, T. A., Rouse, B. T., Kerley, M. K., Blair, P. J., Godfrey, V. L., Kuklin, N. A., Bouley, D. M., Thomas, J., Kanangat, S., & Mucenski, M. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.1685 · Cited by 440
IgG Subclasses in Selective IgA Deficiency: Importance of IgG2-IgA Deficiency
Oxelius, V.-A., Laurell, A.-B., Lindquist, B., Golebiowska, H., Axelsson, U., Björkander, J., & Hanson, L. Å. (1981) · New England Journal of Medicine · doi:10.1056/nejm198106113042408 · Cited by 326
Snapper, C. M., Zelazowski, P., Rosas, F. R., Kehry, M. R., Tian, M., Baltimore, D., & Sha, W. C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.183 · Cited by 302
PEN-SIZED DIGITAL 30-SECOND BLOOD GLUCOSE METER
Matthews, D. R., Bown, E., Watson, A., Holman, R. R., Steemson, J., Hughes, S., & Scott, D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92802-9 · Cited by 300
Doi, T. S., Takahashi, T., Taguchi, O., Azuma, T., & Obata, Y. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.953 · Cited by 292
Rn, A. G., Hammarström, L., Gustafson, R., Nyström, T., Smith, C. I. E., Gustafson, R., Jonsson, E., Gardulf, A., Jonsson, E., Möller, G., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90346-1 · Cited by 266
Self-citationPrimary immunodeficiency diseases. A molecular and genetic approach.
Shigeoka, A. O. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990903)86:1<92::aid-ajmg21>3.0.co;2-0 · Cited by 263
Switch Transcripts in Immunoglobulin Class Switching
Lorenz, M., Jung, S., & Radbruch, A. (1995) · Science · doi:10.1126/science.7892607 · Cited by 252
CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.
Farrington, M., Grosmaire, L. S., Nonoyama, S., Fischer, S. H., Hollenbaugh, D., Ledbetter, J. A., Noelle, R. J., Aruffo, A., & Ochs, H. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.1099 · Cited by 227
Primary immunodeficiency diseases. Report of a WHO Scientific Group.
(1992) · PubMed Central · Cited by 204
Harriman, G. R., Bogue, M., Rogers, P., Finegold, M., Pacheco, S., Bradley, A., Zhang, Y., & Mbawuike, I. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.2521 · Cited by 201
Increased susceptibility to mycoplasma infection in patients with hypogammaglobulinemia
Roifman, C. M., Pandu Rao, C., Lederman, H. M., Lavi, S., Quinn, P., & Gelfand, E. W. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90812-0 · Cited by 165
The genetics and complexity of allergy and asthma
Barnes, K. C., & Marsh, D. G. (1998) · Immunology Today · doi:10.1016/s0167-5699(97)01241-3 · Cited by 156
Aukrust, P., Lien, E., Kristoffersen, A., Müller, F., Haug, C. J., Espevik, T., & Ss, F. (1996) · Blood · doi:10.1182/blood.v87.2.674.bloodjournal872674 · Cited by 152
Encephalomyelitis in primary hypogammaglobulinaemia
Rudge, P., WEBSTER, A. D. B., Révész, T., Warner, T. T., Español, T., Cunningham‐Rundles, C., & Hyman, N. (1996) · Brain · doi:10.1093/brain/119.1.1 · Cited by 147
Studies on the enteropathy associated with primary hypogammaglobulinaemia.
Teahon, K., Webster, A., Price, A. B., et al. (1994) · Gut · doi:10.1136/gut.35.9.1244 · Cited by 144
Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA.
Brière, F., Bridon, J., Chevet, D., Souillet, G., Bienvenu, F., Guret, C., Martínez-Valdez, H., & Banchereau, J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117354 · Cited by 139
Common variable immunodeficiency: how many diseases?
Spickett, G. P., Farrant, J., North, M. E., Zhang, J.-G., Morgan, L., & WEBSTER, A. D. B. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01086-4 · Cited by 138
IgA Deficiency**This article was accepted for publication on 17 January 1997.
Burrows, P. D., & Cooper, M. D. (1997) · Advances in immunology · doi:10.1016/s0065-2776(08)60744-0 · Cited by 138
Fujieda, S., Zhang, K., & Saxon, A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2318 · Cited by 137
Vořechovský, I., WEBSTER, A. D. B., Plebani, A., & Hammarström, L. L. G. (1999) · The American Journal of Human Genetics · doi:10.1086/302326 · Cited by 126
Self-citationX-linked immunodeficiency with hyper-IgM (XHIM)
Notarangelo, L. D., & Hayward, A. R. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01142.x · Cited by 112
North, M. E., Ivory, K., Funauchi, M., WEBSTER, A. D. B., Lane, A., & Farrant, J. (1996) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-795.x · Cited by 108
Defect in IgV gene somatic hypermutation in Common Variable Immuno-Deficiency syndrome
Lévy, Y., Gupta-Rossi, N., Deist, F. L., Cordier, C., Fischer, A., Weill, J., & Reynaud, C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13135 · Cited by 104
Hiroi, T., Yanagita, M., Iijima, H., Iwatani, K., Yoshida, T., Takatsu, K., & Kiyono, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.821 · Cited by 101
Hiroi, T., Yanagita, M., Iijima, H., et al. (1999) · PubMed · Cited by 95
Lack of association of secretory component with IgA in J chain-deficient mice
Hendrickson, B. A., Rindisbacher, L., Corthésy, B., Kendall, D., Waltz, D. A., Neutra, M. R., & Seidman, J. G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.2.750 · Cited by 93
Harriman, G. R., Bradley, A., Das, S., Rogers-Fani, P. M., & Davis, A. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118438 · Cited by 89
Вадимовна, К. И., Amlot, P. L., WEBSTER, A. D. B., & Farrant, J. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.d01-993.x · Cited by 89
Durandy, A., Hivroz, C., Mazerolles, F., Schiff, C., Bernard, F., Jouanguy, E., Revy, P., Santo, J. P. D., Gauchat, J., Bonnefoy, J., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2576 · Cited by 88
WEBSTER, A. D. B., Rotbart, H. A., Tom, W., Rudge, P., & Hyman, N. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.4.657 · Cited by 61
Immunoglobulin replacement therapy by self-infusion at home.
Chapel, H., Brennan, V., & Delson, E. (1988) · PubMed · Cited by 59
IMMUNODEFICIENCY REVIEWEarly B cell defects
Gaspar, H. B., & Conley, M. E. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01192.x · Cited by 58
Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia
Bjøro, K. (1999) · QJM · doi:10.1093/qjmed/92.8.433 · Cited by 54
Fischer, M. B., Wolf, H. M., Hauber, I., Eggenbauer, H., Thon, V., Sasgary, M., & Eibl, M. M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260136 · Cited by 51
Genetic Approach to Common Variable Immunodeficiency and IgA Deficiency
Hammarström, L. L. G. (2013) · Oxford University Press eBooks · doi:10.1093/med/9780195389838.003.0028 · Cited by 36
Self-citationInterleukin 10 and immune restoration in common variable immunodeficiency
Zielen, S., Bauscher, P., Hofmann, D., & Meuer, S. C. (1993) · The Lancet · doi:10.1016/0140-6736(93)91746-9 · Cited by 35
Islam, K. B., Baskin, B., Christensson, B., et al. (1994) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06006.x · Cited by 24
Captopril-induced IgA deficiency
Hammarström, L. L. G., Smith, C. I. E., & Berg, U. (1991) · The Lancet · doi:10.1016/0140-6736(91)91220-o · Cited by 20
Self-citation
Cited by
British Thoracic Society guideline for non-CFbronchiectasis
Pasteur, M. C., Bilton, D., Hill, A. T., & on behalf of the British Thoracic Society Bronchiectasis (non-CF) Guideline Group (2010) · Thorax · doi:10.1136/thx.2010.136119 · Cited by 1,046
International Consensus Document (ICON): Common Variable Immunodeficiency Disorders
Bonilla, F. A., Barlan, I., Chapel, H., Costa-Carvalho, B. T., Cunningham-Rundles, C., de la Morena, M. T., Espinosa-Rosales, F. J., Hammarström, L., Nonoyama, S., Quinti, I., et al. (2016) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2015.07.025 · Cited by 872
Self-citationHomozygous loss of ICOS is associated with adult-onset common variable immunodeficiency
Grimbacher, B., Hutloff, A., Schlesier, M., Glocker, E., Warnatz, K., Dräger, R., Eibel, H., Fischer, B., Schäffer, A. A., Mages, H. W., et al. (2003) · Nature Immunology · doi:10.1038/ni902 · Cited by 733
The function of immunoglobulin A in immunity
Woof, J. M., & Kerr, M. A. (2006) · The Journal of Pathology · doi:10.1002/path.1877 · Cited by 716
Yel, L. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9357-x · Cited by 580
Metadata
- Authors
- Hammarström, L., Vorechovsky, I., & Webster, D.
- Venue
- Clinical and Experimental Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-05
- Volume
- 120
- Issue
- 2
- Pages
- 225-231
- ISSN
- 0009-9104 (ISSN-L)
- 1365-2249
- OpenAlex
- W1974653861
- Cited by
- 422
- References
- 43
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.